Last fall, Johns Hopkins School of Nursing through its Institute for Policy Solutions conducted a survey on health inequities and the full report from that survey was released weeks ago. The findings of that poll offer valuable insights that policymakers and all stakeholders need to weigh while making decisions impacting the health of Americans.
The majority (70%) of the respondents say health care is a right and that it shouldn’t be treated as a privilege. The survey found that while there is a sense that Americans are heavily polarized on national issues, this isn’t the case when it comes to matters of health care.
Notably, 62% of those who participated in the survey revealed that improving health care for everyone will be extremely important or very important as they make voting decisions during the upcoming midterms. This suggests that candidates who are passionate about removing inequities on matters of health care could have an upper hand in appealing to voters.
81% of the respondents believe that preventive health care is vital to keeping Americans healthy. Study participants (74%) also expressed a desire to have preventive health care delivered in the languages that recipients are comfortable speaking and using.
On health care insurance coverage, 79% said no one should be denied coverage on the basis of having a preexisting medical condition. 66% said health care services should be billed uniformly and the cost shouldn’t vary based on the type of insurance an individual has. These views call for a serious examination of the health insurance system as the way it is designed could be contributing to challenges to equity and access.
While there is general agreement that issues of equity need to be addressed in the health care system, survey participants had varying views regarding how much priority ought to be given to the most impacted people/groups as issues of equity are addressed.
Guilamo-Ramos, the ED of the Institute for Policy Solutions, says there is a need to shift from thinking that steps taken to improve health care for a certain group means that something has to be taken from another group. He explains that the best way to address these issues is by setting universal targets and then directing more effort to fix the systemic issues impacting the most vulnerable groups so that they can be brought to the same level as others who don’t face the same hurdles.
For firms like Astiva Health that focus on providing health coverage to vulnerable communities like racial minorities, the realities of the inequities in health care access and delivery are all too apparent and addressing those issues in a systemic way would be hugely welcomed.
About BioMedWire
BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer
BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com
BioMedWire is powered by IBN
At the core of Cardio Diagnostics’ approach is the use of artificial intelligence to integrate…
Researchers have developed a urine test that can screen for tumor DNA and detect whether a patient has…
BioMedWire Editorial Coverage: The biotechnology industry is experiencing a subtle yet meaningful transformation that is…
Primary and metastatic central nervous system (CNS) tumors can have extraordinary biological and anatomical complexity,…
Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. The…
BioMedWire Editorial Coverage: Biotechnology is undergoing a quiet but profound transformation, one that is reshaping how…